A unique cross-linked hyaluronic acid canalicular gel designed for lacrimal occlusion, which is preservative-free and non-allergenic¹

Each administration provides dry eye relief for 6 months²

Designed to have an immediate effect and to adapt to each patient’s unique anatomy, resulting in ease of administration and patient comfort²

Intended for use in adult patients experiencing dry eye symptoms¹

While Lacrifill^® is generally well-tolerated, the most prevalent adverse event reported is epiphora (overflow of tears); for full instructions for use, contraindications, and a complete list of potential adverse events, please see the IFU

Lacrifill^® is a FDA-cleared and CE-marked medical device

Lacrifill^® comes in a pre-filled syringe with 0.6ml of gel, containing enough gel to fully fill both inferior canaliculi of a single patient¹

Lacrifill^® can be administered by healthcare professionals such as ophthalmologists and optometrists in a standard practice setting¹

Lacrifill^®’s administration relies on 3 key steps